Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
35.40
-0.69 (-1.91%)
May 13, 2025, 4:00 PM - Market closed
Ultragenyx Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 127.06 | 173.73 | 213.58 | 132.94 | 307.58 | 713.53 | Upgrade
|
| Short-Term Investments | 367.39 | 436.3 | 363.63 | 614.82 | 432.61 | 488.01 | Upgrade
|
| Cash & Short-Term Investments | 494.44 | 610.03 | 577.21 | 747.76 | 740.2 | 1,202 | Upgrade
|
| Cash Growth | 19.99% | 5.68% | -22.81% | 1.02% | -38.40% | 59.09% | Upgrade
|
| Accounts Receivable | 98.84 | 121.8 | 73.39 | 40.45 | 28.43 | 23.09 | Upgrade
|
| Other Receivables | 4 | 1.8 | 1.1 | 6.4 | 16 | 9.6 | Upgrade
|
| Receivables | 102.84 | 123.6 | 74.49 | 46.85 | 44.43 | 32.69 | Upgrade
|
| Inventory | 46.03 | 45.01 | 33.97 | 26.77 | 16.23 | 13.05 | Upgrade
|
| Prepaid Expenses | 47.37 | 31.68 | 44.51 | - | 55.75 | 37.18 | Upgrade
|
| Restricted Cash | 8.48 | 6.81 | 2.01 | 0.86 | - | 10.85 | Upgrade
|
| Other Current Assets | - | - | - | 61.66 | - | - | Upgrade
|
| Total Current Assets | 699.16 | 817.12 | 732.18 | 883.9 | 856.6 | 1,295 | Upgrade
|
| Property, Plant & Equipment | 260.91 | 291.43 | 314.47 | 285.73 | 176.18 | 114.04 | Upgrade
|
| Long-Term Investments | 68.56 | 135 | 199.9 | 148.97 | 293.86 | 165.88 | Upgrade
|
| Goodwill | 44.41 | 44.41 | 44.41 | 44.41 | 44.41 | 44.41 | Upgrade
|
| Other Intangible Assets | 176.52 | 178.31 | 166.27 | 160.11 | 130.79 | 131.11 | Upgrade
|
| Other Long-Term Assets | 62.37 | 37.18 | 33.79 | 22.34 | 20.56 | 6.71 | Upgrade
|
| Total Assets | 1,312 | 1,503 | 1,491 | 1,545 | 1,522 | 1,760 | Upgrade
|
| Accounts Payable | 47.45 | 38.76 | 42.11 | 43.27 | 17.14 | 12.92 | Upgrade
|
| Accrued Expenses | 173.01 | 240.97 | 196.49 | 204.68 | 145.56 | 108.49 | Upgrade
|
| Current Portion of Long-Term Debt | 57.38 | 49.85 | 29.24 | - | - | - | Upgrade
|
| Current Portion of Leases | 10.49 | 10.3 | 12.6 | 11.78 | 11.07 | 8.98 | Upgrade
|
| Current Unearned Revenue | - | - | - | 1.48 | 7.61 | 59.22 | Upgrade
|
| Other Current Liabilities | 3.35 | 4.28 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 291.67 | 344.15 | 280.44 | 261.21 | 181.37 | 189.61 | Upgrade
|
| Long-Term Debt | 794.05 | 819.82 | 862.33 | 875.44 | 351.79 | 335.67 | Upgrade
|
| Long-Term Leases | 27.79 | 30.04 | 30.57 | 19.81 | 30.9 | 39.25 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 1.47 | 7.35 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 30.06 | 30.06 | 30.06 | 31.67 | 33.31 | 33.31 | Upgrade
|
| Other Long-Term Liabilities | 17.12 | 17.08 | 12.21 | 4.82 | 1.01 | - | Upgrade
|
| Total Liabilities | 1,161 | 1,241 | 1,216 | 1,193 | 599.84 | 605.18 | Upgrade
|
| Common Stock | 0.09 | 0.09 | 0.08 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 4,252 | 4,213 | 3,662 | 3,140 | 2,997 | 2,773 | Upgrade
|
| Retained Earnings | -4,108 | -3,957 | -3,388 | -2,781 | -2,074 | -1,620 | Upgrade
|
| Treasury Stock | -7.57 | -3.59 | -0.43 | - | - | - | Upgrade
|
| Comprehensive Income & Other | 7.23 | 2.95 | 1.08 | -6.57 | -1.4 | 0.69 | Upgrade
|
| Total Common Equity | 144.25 | 255.3 | 275.41 | 352.49 | 922.56 | 1,154 | Upgrade
|
| Minority Interest | 7 | 7 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 151.25 | 262.3 | 275.41 | 352.49 | 922.56 | 1,154 | Upgrade
|
| Total Liabilities & Equity | 1,312 | 1,503 | 1,491 | 1,545 | 1,522 | 1,760 | Upgrade
|
| Total Debt | 889.7 | 910.01 | 934.74 | 907.03 | 393.76 | 383.89 | Upgrade
|
| Net Cash (Debt) | -326.69 | -164.98 | -157.63 | -10.3 | 605.37 | 828.15 | Upgrade
|
| Net Cash Growth | - | - | - | - | -26.90% | 102.96% | Upgrade
|
| Net Cash Per Share | -3.49 | -1.82 | -2.14 | -0.15 | 8.93 | 13.61 | Upgrade
|
| Filing Date Shares Outstanding | 94.38 | 92.5 | 82.34 | 70.22 | 69.38 | 66.95 | Upgrade
|
| Total Common Shares Outstanding | 93.74 | 92.48 | 82.32 | 70.2 | 69.34 | 66.82 | Upgrade
|
| Working Capital | 407.49 | 472.97 | 451.75 | 622.69 | 675.24 | 1,106 | Upgrade
|
| Book Value Per Share | 1.54 | 2.76 | 3.35 | 5.02 | 13.30 | 17.28 | Upgrade
|
| Tangible Book Value | -76.68 | 32.58 | 64.74 | 147.98 | 747.37 | 978.86 | Upgrade
|
| Tangible Book Value Per Share | -0.82 | 0.35 | 0.79 | 2.11 | 10.78 | 14.65 | Upgrade
|
| Land | - | 16.62 | 16.62 | 16.62 | 15.49 | 11.72 | Upgrade
|
| Buildings | - | 181.58 | 181.36 | 2.8 | - | - | Upgrade
|
| Machinery | - | 120.41 | 116.26 | 70.28 | 54.31 | 41.63 | Upgrade
|
| Construction In Progress | - | - | - | 189.45 | 76.85 | 17.65 | Upgrade
|
| Leasehold Improvements | - | 58.02 | 58.68 | 43.94 | 44.08 | 39.36 | Upgrade
|
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.